Suppr超能文献

3%高渗盐水溶液与20%甘露醇治疗动脉瘤性蛛网膜下腔出血患者颅内高压的临床疗效比较

[Comparison clinical efficacy of 3% hypertonic saline solution with 20% mannitol in treatment of intracranial hypertension in patients with aneurysmal subarachnoid hemorrhage].

作者信息

Huang Xue-cai, Yang Ling-ling

机构信息

Department of Neurosurgery, Lishui Central Hospital, Lishui 323000, China.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Jul;44(4):389-95. doi: 10.3785/j.issn.1008-9292.2015.07.07.

Abstract

OBJECTIVE

To compare the efficacy of 3% hypertonic saline solution with 20% mannitol in treatment of intracranial hypertension in patients with aneurysmal subarachnoid hemorrhage.

METHODS

An alternating treatment protocol was used to compare the efficacy of 160 mL 3% hypertonic saline solution (HSS) with 150 mL 20% mannitol for episodes of increased intracranial pressure (ICP) in patients with aneurysmal subarachnoid hemorrhage. The dependent variables were the extent and duration of reduction of increased ICP after each event.

RESULTS

Both 3% HSS and 20% mannitol rapidly decreased the ICP in patients with aneurysmal subarachnoid hemorrhage (P <0.01). No difference between two medications in the extent of duration of ICP and reduction of action (P >0.05).

CONCLUSION

3% HSS should be considered as the first-line osmotic drug in treatment of intracranial hypertension in patients with aneurysmal subarachnoid hemorrhage.

摘要

目的

比较3%高渗盐水溶液与20%甘露醇治疗动脉瘤性蛛网膜下腔出血患者颅内高压的疗效。

方法

采用交替治疗方案,比较160 mL 3%高渗盐水溶液(HSS)与150 mL 20%甘露醇治疗动脉瘤性蛛网膜下腔出血患者颅内压(ICP)升高发作的疗效。因变量为每次事件后ICP升高降低的程度和持续时间。

结果

3% HSS和20%甘露醇均能迅速降低动脉瘤性蛛网膜下腔出血患者的ICP(P<0.01)。两种药物在ICP降低程度和作用持续时间方面无差异(P>0.05)。

结论

3% HSS应被视为治疗动脉瘤性蛛网膜下腔出血患者颅内高压的一线渗透性药物。

相似文献

2
Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries.
J Neurosurg. 2011 Feb;114(2):545-8. doi: 10.3171/2010.5.JNS091685. Epub 2010 Nov 19.
3
Hypertonic Saline for Increased Intracranial Pressure After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review.
World Neurosurg. 2017 Sep;105:1-6. doi: 10.1016/j.wneu.2017.05.085. Epub 2017 May 23.
7
Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline.
Neurosurgery. 1999 May;44(5):1055-63; discussion 1063-4. doi: 10.1097/00006123-199905000-00064.
10
Hypertonic saline and mannitol in patients with traumatic brain injury: A systematic and meta-analysis.
Medicine (Baltimore). 2020 Aug 28;99(35):e21655. doi: 10.1097/MD.0000000000021655.

本文引用的文献

1
High-osmolarity saline in neurocritical care: systematic review and meta-analysis.
Crit Care Med. 2013 May;41(5):1353-60. doi: 10.1097/CCM.0b013e31827ca4b3.
2
Current purpose and practice of hypertonic saline in neurosurgery: a review of the literature.
World Neurosurg. 2014 Dec;82(6):1307-18. doi: 10.1016/j.wneu.2013.02.027. Epub 2013 Feb 9.
3
Hyperosmolar therapy for raised intracranial pressure.
N Engl J Med. 2012 Aug 23;367(8):746-52. doi: 10.1056/NEJMct1206321.
7
Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis.
J Neurosurg. 2012 Jan;116(1):210-21. doi: 10.3171/2011.7.JNS102142. Epub 2011 Sep 23.
9
Critical care guidelines on the endovascular management of cerebral vasospasm.
Neurocrit Care. 2011 Sep;15(2):336-41. doi: 10.1007/s12028-011-9600-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验